Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis

PURPOSE OF REVIEWAmphotericin B (AmpB) is considered the first-line treatment for visceral leishmaniasis in areas in which resistance to antimony is prevalent. This review describes recent advances in clinically available and novel drug delivery systems of AmpB to treat visceral leishmaniasis. RECEN...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current opinion in infectious diseases 2012-12, Vol.25 (6), p.695-702
Hauptverfasser:	Mohamed-Ahmed, Abeer H.A, Brocchini, Stephen, Croft, Simon L
Format:	Artikel
Sprache:	eng
Schlagworte:	Amphotericin B - administration & dosage Amphotericin B - pharmacokinetics Antiprotozoal Agents - administration & dosage Antiprotozoal Agents - pharmacokinetics Chemistry, Pharmaceutical Drug Delivery Systems Humans Leishmaniasis, Visceral - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!